Sage Labs, Caribou Bio Ink Genome Editing Partnership | GenomeWeb

NEW YORK (GenomeWeb News) – Sage Labs said today it has entered into a partnership and licensing agreement that provides it access to Caribou Biosciences' intellectual property related to the CRISPR/Cas9 genome editing system.

As part of the deal, Sage will have exclusive rights to Caribou's IP to produce and sell genetically engineered rats. It also gains non-exclusive rights for mouse and rabbit models.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.

A technology that has the potential to make species go extinct could be used against the Zika virus. 

University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.

If science funding agencies can talk tough about sexual harassers, shouldn't they also put their talk into action?